Bactiguard Holding AB (publ) (BACTI-B) - Total Assets
Based on the latest financial reports, Bactiguard Holding AB (publ) (BACTI-B) holds total assets worth Skr545.06 Million SEK (≈ $58.66 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See BACTI-B total equity for net asset value and shareholders' equity analysis.
Bactiguard Holding AB (publ) - Total Assets Trend (2008–2025)
This chart illustrates how Bactiguard Holding AB (publ)'s total assets have evolved over time, based on quarterly financial data.
Bactiguard Holding AB (publ) - Asset Composition Analysis
Current Asset Composition (December 2025)
Bactiguard Holding AB (publ)'s total assets of Skr545.06 Million consist of 22.8% current assets and 77.2% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr44.26 Million | 8.1% |
| Accounts Receivable | Skr45.95 Million | 8.4% |
| Inventory | Skr21.88 Million | 4.0% |
| Property, Plant & Equipment | Skr93.34 Million | 17.1% |
| Intangible Assets | Skr51.93 Million | 9.5% |
| Goodwill | Skr248.82 Million | 45.7% |
Asset Composition Trend (2008–2025)
This chart illustrates how Bactiguard Holding AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Bactiguard Holding AB (publ) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Bactiguard Holding AB (publ)'s current assets represent 22.8% of total assets in 2025, an increase from 0.0% in 2008.
- Cash Position: Cash and equivalents constituted 8.1% of total assets in 2025, up from 0.0% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 54.0% of total assets, an increase from 0.0% in 2008.
- Asset Diversification: The largest asset category is goodwill at 45.7% of total assets.
Bactiguard Holding AB (publ) Competitors by Total Assets
Key competitors of Bactiguard Holding AB (publ) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.15 Billion |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607
|
China | CN¥988.48 Million |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS
|
USA | $139.92 Million |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO
|
India | Rs8.57 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
|
Aligned Genetics Inc
KQ:238120
|
Korea | ₩45.11 Billion |
|
Heramed Ltd
AU:HMD
|
Australia | AU$1.04 Million |
|
Acarix A/S
ST:ACARIX
|
Sweden | Skr48.33 Million |
Bactiguard Holding AB (publ) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.67 | 0.69 | 3.05 |
| Quick Ratio | 1.38 | 0.60 | 2.11 |
| Cash Ratio | 0.60 | 0.41 | 0.00 |
| Working Capital | Skr49.85 Million | Skr-87.38 Million | Skr75.73 Million |
Bactiguard Holding AB (publ) - Advanced Valuation Insights
This section examines the relationship between Bactiguard Holding AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.82 |
| Latest Market Cap to Assets Ratio | 0.11 |
| Asset Growth Rate (YoY) | -16.9% |
| Total Assets | Skr545.06 Million |
| Market Capitalization | $61.64 Million USD |
Valuation Analysis
Below Book Valuation: The market values Bactiguard Holding AB (publ)'s assets below their book value (0.11x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Bactiguard Holding AB (publ)'s assets decreased by 16.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Bactiguard Holding AB (publ) (2008–2025)
The table below shows the annual total assets of Bactiguard Holding AB (publ) from 2008 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr545.06 Million ≈ $58.66 Million |
-16.90% |
| 2024-12-31 | Skr655.91 Million ≈ $70.59 Million |
-0.95% |
| 2023-12-31 | Skr662.17 Million ≈ $71.26 Million |
-18.02% |
| 2022-12-31 | Skr807.70 Million ≈ $86.92 Million |
-4.90% |
| 2021-12-31 | Skr849.29 Million ≈ $91.40 Million |
+25.78% |
| 2020-12-31 | Skr675.22 Million ≈ $72.66 Million |
+5.28% |
| 2019-12-31 | Skr641.37 Million ≈ $69.02 Million |
+9.17% |
| 2018-12-31 | Skr587.48 Million ≈ $63.22 Million |
-6.06% |
| 2017-12-31 | Skr625.39 Million ≈ $67.30 Million |
-1.06% |
| 2016-12-31 | Skr632.07 Million ≈ $68.02 Million |
-6.53% |
| 2015-12-31 | Skr676.25 Million ≈ $72.77 Million |
-16.63% |
| 2014-12-31 | Skr811.13 Million ≈ $87.29 Million |
+13.09% |
| 2013-12-31 | Skr717.23 Million ≈ $77.19 Million |
+1.93% |
| 2012-12-31 | Skr703.63 Million ≈ $75.72 Million |
+8.13% |
| 2011-12-31 | Skr650.74 Million ≈ $70.03 Million |
+20.54% |
| 2010-12-31 | Skr539.84 Million ≈ $58.10 Million |
-12.84% |
| 2009-12-31 | Skr619.36 Million ≈ $66.65 Million |
-10.27% |
| 2008-12-31 | Skr690.26 Million ≈ $74.28 Million |
-- |
About Bactiguard Holding AB (publ)
Bactiguard Holding AB (publ), a medTech company, provides infection prevention technology and solutions in orthopedics, cardiology, neurology, urology, and vascular access areas. It also operates through license partnerships with global MedTech companies that apply the technology to medical devices and sell them under own brand and co-branded. The company also has a portfolio of wound management … Read more